Global Retirement Partners LLC Grows Stake in Bruker Co. (NASDAQ:BRKR)

Global Retirement Partners LLC increased its position in Bruker Co. (NASDAQ:BRKR) by 16.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,135 shares of the medical research company’s stock after acquiring an additional 726 shares during the period. Global Retirement Partners LLC’s holdings in Bruker were worth $301,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. True Wealth Design LLC grew its stake in shares of Bruker by 4,636.4% during the 3rd quarter. True Wealth Design LLC now owns 521 shares of the medical research company’s stock valued at $36,000 after purchasing an additional 510 shares during the period. Eagle Bay Advisors LLC boosted its holdings in shares of Bruker by 2,324.1% in the fourth quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company’s stock worth $41,000 after buying an additional 674 shares during the last quarter. UMB Bank n.a. grew its position in Bruker by 37.5% during the fourth quarter. UMB Bank n.a. now owns 909 shares of the medical research company’s stock valued at $53,000 after buying an additional 248 shares during the period. GAMMA Investing LLC increased its holdings in Bruker by 47.5% during the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company’s stock valued at $75,000 after buying an additional 412 shares during the last quarter. Finally, Capital Performance Advisors LLP purchased a new position in shares of Bruker during the 3rd quarter worth $77,000. Institutional investors own 79.52% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have recently commented on BRKR. UBS Group assumed coverage on Bruker in a research note on Tuesday, December 10th. They issued a “neutral” rating and a $66.00 price objective for the company. Bank of America upped their price target on Bruker from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Friday, December 13th. TD Cowen cut their price objective on Bruker from $72.00 to $70.00 and set a “hold” rating for the company in a research note on Wednesday, November 6th. Barclays decreased their target price on shares of Bruker from $69.00 to $65.00 and set an “overweight” rating on the stock in a research note on Monday, February 10th. Finally, Wells Fargo & Company dropped their price target on shares of Bruker from $78.00 to $75.00 and set an “overweight” rating for the company in a research report on Wednesday, November 6th. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $70.50.

Bruker Stock Performance

Shares of NASDAQ BRKR opened at $51.89 on Tuesday. The company has a market cap of $7.87 billion, a P/E ratio of 68.28, a P/E/G ratio of 2.16 and a beta of 1.16. Bruker Co. has a 52-week low of $48.07 and a 52-week high of $94.86. The company has a debt-to-equity ratio of 1.15, a quick ratio of 0.77 and a current ratio of 1.60. The firm’s fifty day moving average is $56.63 and its two-hundred day moving average is $59.95.

Bruker (NASDAQ:BRKR) last issued its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%. As a group, analysts anticipate that Bruker Co. will post 2.69 EPS for the current fiscal year.

Bruker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Monday, March 17th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date of this dividend is Monday, March 17th. Bruker’s dividend payout ratio (DPR) is presently 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.